Marson T. The SANAD II study of effectiveness of valproate or levetiracetam in generalised and unclassifiable epilepsy: an un-blinded randomised controlled trial. 5th European Academy of Neurology (EAN) Congress, abstract O4125.
Tenecteplase na 4,5 uur: geen klinisch voordeel bij ischemische beroerte
jul 2024 | Neuro-vasculair